According to Cancer Research UK, some patients are surviving with stage four melanoma for a long period despite new therapies.
However, research indicates that just half of people with this stage of the illness survive for more than six years on average.
In April 2023, Ms. Murphy started immunotherapy, but she found it difficult to handle the necessary dosages.
After undergoing two oral chemotherapy treatments, she had a serious allergic response that included a rash that traveled down her neck within ten days.
She was sent to the hospital immediately after developing sepsis, which was brought on by a compromised immune system.
